Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease

Mild cognitive impairment (MCI) is a syndrome which, depending on various neurobiological, psychological and social factors, carries a high risk of developing into dementia. As far as diagnostic uncertainty and the heterogeneous underlying pathophysiological mechanisms are concerned, only limited th...

Descripción completa

Detalles Bibliográficos
Autores principales: Karakaya, Tarik, Fußer, Fabian, Schröder, Johannes, Pantel, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580783/
https://www.ncbi.nlm.nih.gov/pubmed/23814542
http://dx.doi.org/10.2174/157015913804999487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580783/
https://www.ncbi.nlm.nih.gov/pubmed/23814542
http://dx.doi.org/10.2174/157015913804999487

Ejemplares similares